Cargando…
Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
BACKGROUND: Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PURPO...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534355/ https://www.ncbi.nlm.nih.gov/pubmed/36211578 http://dx.doi.org/10.3389/fcvm.2022.929078 |
_version_ | 1784802523432878080 |
---|---|
author | Wang, Qiong Wang, Yurong Xu, Danyan |
author_facet | Wang, Qiong Wang, Yurong Xu, Danyan |
author_sort | Wang, Qiong |
collection | PubMed |
description | BACKGROUND: Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PURPOSE: We review the mechanisms of CD4(+) T subsets, i.e., helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis, focusing on the role of interleukin (IL)-17, IL-10, and other cytokines in this disease and the factors influencing the effects of these cytokines. RESULTS: IL-17 secreted by Th17 cells can promote atherosclerosis, but few studies have reported that IL-17 can also stabilize atherosclerotic plaques. Tregs play a protective role in atherosclerosis, and Th17/Treg imbalance also plays an important role in atherosclerosis. CONCLUSION: The immune response is important in regulating atherosclerosis, and studying the mechanism of action of each immune cell on atherosclerosis presents directions for the treatment of atherosclerosis. Nevertheless, the current studies are insufficient for elucidating the mechanism of action, and further in-depth studies are needed to provide a theoretical basis for clinical drug development. |
format | Online Article Text |
id | pubmed-9534355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95343552022-10-06 Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis Wang, Qiong Wang, Yurong Xu, Danyan Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PURPOSE: We review the mechanisms of CD4(+) T subsets, i.e., helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis, focusing on the role of interleukin (IL)-17, IL-10, and other cytokines in this disease and the factors influencing the effects of these cytokines. RESULTS: IL-17 secreted by Th17 cells can promote atherosclerosis, but few studies have reported that IL-17 can also stabilize atherosclerotic plaques. Tregs play a protective role in atherosclerosis, and Th17/Treg imbalance also plays an important role in atherosclerosis. CONCLUSION: The immune response is important in regulating atherosclerosis, and studying the mechanism of action of each immune cell on atherosclerosis presents directions for the treatment of atherosclerosis. Nevertheless, the current studies are insufficient for elucidating the mechanism of action, and further in-depth studies are needed to provide a theoretical basis for clinical drug development. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9534355/ /pubmed/36211578 http://dx.doi.org/10.3389/fcvm.2022.929078 Text en Copyright © 2022 Wang, Wang and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wang, Qiong Wang, Yurong Xu, Danyan Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis |
title | Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis |
title_full | Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis |
title_fullStr | Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis |
title_full_unstemmed | Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis |
title_short | Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis |
title_sort | research progress on th17 and t regulatory cells and their cytokines in regulating atherosclerosis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534355/ https://www.ncbi.nlm.nih.gov/pubmed/36211578 http://dx.doi.org/10.3389/fcvm.2022.929078 |
work_keys_str_mv | AT wangqiong researchprogressonth17andtregulatorycellsandtheircytokinesinregulatingatherosclerosis AT wangyurong researchprogressonth17andtregulatorycellsandtheircytokinesinregulatingatherosclerosis AT xudanyan researchprogressonth17andtregulatorycellsandtheircytokinesinregulatingatherosclerosis |